FDA Drug Application (091544) for LITHIUM CARBONATE by GLENMARK PHARMS INC

Back to FDA Applications sponsored by GLENMARK PHARMS INC

Application Number091544
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLITHIUM CARBONATE
Active IngredientLITHIUM CARBONATE

Active IngredientCount
List of drugs with Active Ingredient LITHIUM CARBONATE7


Back to FDA Applications sponsored by GLENMARK PHARMS INC